Diabetic heart disease: Clinical considerations

Heart

Volumn 85, Issue 4, 2001, Pages 463-469

  Timmis, A D ^a  

^a LONDON CHEST HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; ANGINA PECTORIS; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR RISK; DIABETES MELLITUS; DISEASE CONTROL; HEART DISEASE; HEART FAILURE; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; RISK FACTOR; SMOKING CESSATION; SUDDEN DEATH;

ANGINA PECTORIS; CLINICAL TRIALS; DEATH, SUDDEN; DIABETIC ANGIOPATHIES; HEART DISEASES; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; RISK FACTORS;

EID: 0034765765     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Diabetes and cardiovascular risk factors: The Framingham study
2. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: The Whitehall study
3. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial
4. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease
5. Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: Results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy
6. Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents
7. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction: Effects on mortality at 1 year
8. Diabetes and ischemic heart disease
9. Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients
10. Silent myocardial ischaemia: The role of subclinical neuropathy in patients with and without diabetes
11. Prolonged anginal perceptual threshold in diabetes: Effects on exercise capacity and myocardial ischemia
12. Diabetes mellitus and congestive heart failure: Further knowledge needed
13. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38)
14. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 39)
15. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
16. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (trial on reversing endothelial dysfunction) study
17. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
18. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Result of HOPE study and MICRO-HOPE substudy